Trials / Terminated
TerminatedNCT06579300
A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088
A Phase 1 Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the safety, tolerability, and pharmacokinetics of ABBV-1088 in healthy adult Western, Han-Chinese and Japanese participants. This study will also assess drug-drug interaction between itraconazole and ABBV-1088 in healthy adult Western participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-1088 | Oral Capsule |
| DRUG | Placebo for ABBV-1088 | Oral Capsule |
| DRUG | Itraconazole (ITZ) | Oral Capsule |
Timeline
- Start date
- 2024-09-04
- Primary completion
- 2025-09-03
- Completion
- 2025-09-03
- First posted
- 2024-08-30
- Last updated
- 2025-10-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06579300. Inclusion in this directory is not an endorsement.